Patent Ductus Arteriosus After Premature Birth Clinical Trial
Official title:
Hemodynamically Important PDA in Newborns Under 32 Weeks: Clinical and Echocardiographic Findings and Outcomes
To define the characteristics of hemodynamically significant PDA by echocardiography, to investigate the systemic effects of the ductus with cerebral and renal Doppler flow studies, and to determine the oxygen consumption in the cerebral tissue with NIRS in newborns below 32 weeks of age with PDA.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04126512 -
Timing of Surgical PDA Ligation and Neonatal Outcomes
|
||
| Recruiting |
NCT04359134 -
Combined Lung Ultrasounds and Transthoracic Electrical Bioimpedance in Preterm Infants With Respiratory Distress.
|
||
| Recruiting |
NCT05325177 -
PDA Treatment With Ibuprofen and Changes in Tissue Oxygenation.
|
Phase 4 | |
| Active, not recruiting |
NCT03675425 -
The Effects of Phototherapy in Preterm Infants Pda
|
N/A | |
| Recruiting |
NCT04037514 -
Paracetamol Versus Ibuprofen in Premature Infants With Hemodynamically Significant Patent Ductus Arteriosus
|
Phase 3 | |
| Withdrawn |
NCT04025177 -
Indomethacin PK-PD in Extremely Preterm Neonates
|
Phase 2 | |
| Recruiting |
NCT05011149 -
Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT
|
Phase 3 | |
| Recruiting |
NCT03456336 -
Management of the PDA Trial
|
Phase 3 | |
| Recruiting |
NCT05340582 -
Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants
|
Phase 2 | |
| Completed |
NCT05493540 -
Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm Infants
|
Phase 2 |